Skip to main content
logo
Unity Biotechnology, Inc. (UNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0561
+0.0002 (0.36%)
Inactive · Last trade price on Oct 1, 2025

Unity Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
116323984277
Market Cap Growth
-95.94%-49.21%-16.69%-53.86%-69.60%-16.30%
Enterprise Value
71214-1457209
Last Close Price
0.060.981.932.7414.6052.40

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
---164.7817.62-
PB Ratio
-4.712.531.140.691.423.35
P/TBV Ratio
-2.531.140.691.423.35

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
----11.82-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-110.283.630.950.900.960.77
Asset Turnover
---0.000.03-
Quick Ratio
1.872.525.714.845.306.76
Current Ratio
1.952.625.954.925.456.97
Return on Equity (ROE)
-231.27%-148.97%-94.36%-76.90%-85.26%-92.19%
Return on Assets (ROA)
-38.89%-34.43%-25.30%-27.94%-25.20%-37.12%
Return on Invested Capital (ROIC)
-47.83%-41.66%-29.69%-31.20%-26.95%-42.75%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-2848.17%-157.97%-123.04%-114.36%-72.05%-33.85%
FCF Yield
--126.82%-114.52%-135.03%-53.70%-28.48%
Buyback Yield / Dilution
-9.46%-13.90%-55.60%-70.10%-9.73%-16.60%